University of California San Francisco
A rendering of the new research building at Zuckerberg San Francisco General Hospital, as viewed form the 23rd Street entrance to the medical center campus. UC San Francisco is moving forward with
Neuroscientists discovered how the listening brain scans speech to break it down into syllables. The findings provide for the first time a neural basis for the fundamental atoms of language and insights into our perception of the rhythmic poetry of speech.
Three in four patients with anorexia nervosa make a partial recovery. But just 21 percent make a full recovery, a milestone that is most likely to signal permanent remission.
Research shows that after cells are subjected to certain stressful treatments, they appear to gain a new “superpower” that allows them to grow twice as fast as normal — a feature the authors call “supergrowth.”
The University of California is providing this update on efforts to address concerns about its agreements with non-UC medical facilities, including faith-based healthcare facilities.
Using standard animal model of Down syndrome, scientists were able to correct the learning and memory deficits associated with the condition with drugs that target the body’s response to cellular stresses.
We commonly think a full stomach is what tells us to stop eating, but it may be that a stretched intestine plays an even bigger role in making us feel sated.
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.
The faculty, staff and students were honored by Chancellor Sam Hawgood, MBBS, and Vice Chancellor Renee Chapman Navarro, MD, PharmD, during a luncheon on Oct. 24.
New study reveals that peer reviewers do not take conflicts of interest disclosures into account in their recommendations to journal editors, likely because of an absence of clear guidelines on how conflicts should impact their evaluations.
With a $106 million gift from the Weill Family Foundation, UC Berkeley, UC San Francisco, and the University of Washington have launched the Weill Neurohub to speed the development of new therapies for diseases and disorders that affect the brain and nervous system.
Adam L. Boxer answers questions about the potential of "basket trials" to accelerate drug development for dementia and neurodegenerative disease.
The net clinical benefit of anticoagulants for atrial fibrillation decreases with age.
The Kidney Project team reported that UCSF scientists successfully implanted a prototype kidney bioreactor containing functional human kidney cells in large animals without significant safety concerns.
UCSF School of Pharmacy alumna Janet Balbutin, ’68, lost her pharmacy, Paradise Drug, in last year’s Camp Fire, but continues to serve the Paradise community to this day.
With the newly increased scholarships and loans, students, depending on their program of study, can be eligible for approximately $60,000 of financial support per year.
